scholarly journals Clinical performance of the Nova T380® intrauterine device in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report

2002 ◽  
Vol 28 (2) ◽  
pp. 69-72 ◽  
Author(s):  
Michael Cox ◽  
John Tripp ◽  
Sarah Blacksell
Keyword(s):  
Family Planning ◽  
Reproductive Health ◽  
Health Research ◽  
Clinical Performance ◽  
Intrauterine Device ◽  
Research Network ◽  
The Uk

scholarly journals Research approvals iceberg: helping it melt away

2019 ◽  
Vol 20 (1) ◽  
Author(s):  
Simon E. Kolstoe ◽  
David Carpenter
Keyword(s):  
Clinical Research ◽  
Research Ethics ◽  
Health Research ◽  
Ethics Committees ◽  
Research Network ◽  
Regulatory Environment ◽  
Research Ethics Committees ◽  
The Uk ◽  
Governance Processes ◽  
Local Research

Abstract Background In their paper “Research approvals iceberg: how a ‘low-key’ study in England needed 89 professionals to approve it and how we can do better” Petrova and Barclay highlight concerns with the health research regulatory environment in the UK. Discussion As long-standing chairs of NHS research ethics committees, researchers, and also academics in research ethics, we are also often frustrated with the regulatory process in the UK. However, we think that Petrova and Barclay’s analysis is misleading because it conflates research ethics with governance and funding processes, thus failing to adequately distinguish between the national coordinating function of the Health Research Authority, local research governance processes, and interactions with research sponsors and/or the Clinical Research Network.

scholarly journals Effect of Motivational Interviewing on Using Intrauterine Device in Women at High Risk for Pregnancy

2018 ◽  
Vol 6 (7) ◽  
pp. 1305-1309 ◽  
Author(s):  
Katayoon Vakilian ◽  
Sajedeh Molavi ◽  
Ahmad Reza Zamani ◽  
Masoumeh Goodarzi
Keyword(s):  
Family Planning ◽  
High Risk ◽  
Reproductive Health ◽  
Motivational Interviewing ◽  
Birth Control ◽  
Statistical Tests ◽  
Intrauterine Device ◽  
Intervention Group ◽  
Life Quality ◽  
T Test

BACKGROUND: Reproductive health programs help women live healthier. Family planning consultation is an important component of reproductive health. A good family planning consultation can increase the use of effective birth control methods and improve the life quality of people, specifically of those at high risk. One of the most effective birth control techniques is an intrauterine device (IUD).AIM: This study was done to investigate the effect of motivational interviewing (MI) on the use of IUD in women at high risk for pregnancy.METHODS: This random educational trial was conducted in Isfahan on 44 women at high risk for pregnancy in 2015. Subjects were selected through random sampling. First, written informed consent of all samples was gathered, and then the intervention was made in five 45-minute motivational interviewing sessions by the researcher. For this study, a questionnaire was created to measure knowledge, attitude, acceptance, and performance. All the subjects filled this instrument prior and one month after the intervention. Data were then analysed using SPSS 20. The employed statistical tests included dependent t-test, independent t-test, Mann-Whitney, Fischer’s exact test, and McNemar's test.RESULTS: Results suggested that MI significantly improved the use of IUD in the intervention group (p < 0.001). Also, the mean knowledge (p < 0.001) and attitude (p < 0.001) scores significantly increased in the intervention group.CONCLUSION: Due to the role of MI in increasing the use of IUD, embedding this type of consultation in specific programs for changing health behaviours during pregnancy can be beneficial.

scholarly journals Clinical research, national studies and grant applications: United Kingdom National Multidisciplinary Guidelines

2016 ◽  
Vol 130 (S2) ◽  
pp. S216-S217
Author(s):  
N Stafford
Keyword(s):  
Cancer Research ◽  
Clinical Research ◽  
Head And Neck ◽  
Health Research ◽  
Research Network ◽  
Ongoing Research ◽  
Clinical Research Network ◽  
Grant Applications ◽  
The Uk ◽  
Subsidiary Roles

AbstractHead and neck cancer clinical research is thriving. Infrastructure for clinical research is supported through the National Institute for Health Research Clinical Research Network with operates through 15 local clinical research networks for studies within the UK Clinical Research Network Portfolio. The National Clinical Research Institute is a partnership of UK cancer research funders that support high-quality cancer research, although the National Institute for Health Research also has funding streams that will fund cancer-related research. Their websites provide up-to-date information regarding ongoing research projects. Other specialty organisations such as the British Association of Head and Neck Oncologists play important subsidiary roles in supporting research.

Recruitment of cancer patients to National Institute for Health research cancer research network portfolio studies between 2001 and 2011.

2012 ◽  
Vol 30 (15_suppl) ◽  
pp. 6091-6091 ◽  
Author(s):  
Matthew Cooper ◽  
Karen Poole ◽  
David A. Cameron ◽  
Robert Haward ◽  
Peter John Selby ◽  
...  
Keyword(s):  
Cancer Research ◽  
United Kingdom ◽  
National Health Service ◽  
Health Service ◽  
Cancer Patients ◽  
Health Research ◽  
Research Network ◽  
Cancer Research Network ◽  
The United Kingdom ◽  
The Uk

6091 Background: The National Institute for Health Research Cancer Research Network (NCRN) was established in 2001 in England, United Kingdom to improve cancer patient outcomes by improving the coordination, integration and speed of cancer research. Methods: Baseline recruitment of cancer patients in England to clinical studies was around 4% of incident population. Research Networks were established initially in England (NCRN) and then across the UK, co-terminus with clinical cancer service networks, and a per capita based funding model used to provide a research infrastructure to support recruitment to a nationally defined research portfolio. Results: Within 3 years, as the networks were established, recruitment of patients to studies doubled from 10,000 to 20,000 cancer patients per year. Recruitment has continued to increase year on year, supported initially by underspend that had accrued from earlier years in the life of NCRN, and more recently from additional resources invested via the NIHR comprehensive networks. Data for 2010/11 show that over 45,000 cancer patients are now recruited into portfolio studies in England each year, with over 50,000 across the whole of the UK. Conclusions: Dedicated, targeted, clinician-led National Health Service investment into supporting national portfolio studies, has delivered an unprecedented five-fold increase in recruitment of cancer patients into clinical trials across the United Kingdom. This required coordinated research infrastructure, close cooperation with research funders, particularly Cancer Research UK and the National Cancer Research Institute, and the enthusiasm and hard work of many clinicians, patients and others working to deliver clinical cancer care in the National Health Service in the United Kingdom.

Sign in / Sign up

Export Citation Format

Share Document